tiprankstipranks
Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating
PremiumRatingsImmunovant’s Strategic Developments and Financial Strength Justify Buy Rating
27d ago
Immunovant, Inc. Reports Strategic Progress and Financial Results
Premium
Company Announcements
Immunovant, Inc. Reports Strategic Progress and Financial Results
27d ago
Immunovant reports Q4 EPS (64c), consensus (72c)
Premium
The Fly
Immunovant reports Q4 EPS (64c), consensus (72c)
28d ago
Immunovant downgraded to Neutral from Buy at UBS
PremiumThe FlyImmunovant downgraded to Neutral from Buy at UBS
2M ago
Immunovant’s Strategic Developments and Growth Potential Drive Buy Rating
Premium
Ratings
Immunovant’s Strategic Developments and Growth Potential Drive Buy Rating
2M ago
Immunovant’s Strategic Advancements and Targeted Approach Drive Buy Rating
Premium
Ratings
Immunovant’s Strategic Advancements and Targeted Approach Drive Buy Rating
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
Premium
Ratings
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
3M ago
Immunovant price target raised to $61 from $58 at Stifel
Premium
The Fly
Immunovant price target raised to $61 from $58 at Stifel
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100